Sangamo BioSciences | SGMO - Eps Gewinn Pro Aktie

Aktienkurs
0.33
Täglich Wechseln
-0.01 -2.73%
Monatlich
-15.32%
Jährlich
-61.72%
Q1 Prognose
0.32




Eps Veränderung Datum
Alaunos Therapeutics USD -0.53 0.08 2025-09
Alnylam Pharmaceuticals USD 1.25 1.65 2025-12
Alterity Therapeutics Limited AUD 0 0 2023-12
Amgen USD 5.29 0.35 2025-12
Bayer EUR 0.62 0.05 2025-12
BioCryst Pharmaceuticals USD 1.17 1.1 2025-12
Biogen USD 1.99 2.82 2025-12
BioMarin Pharmaceutical USD 0.46 0.34 2025-12
Cipla INR 15.2 1.52 2025-12
Clal Biotechnology ILS -0.04 0.1 2022-12
Compugen USD 0.59 0.67 2025-12
CSL USD 5.07 3 2025-12
Gilead Sciences USD 1.86 0.61 2025-12
GlaxoSmithKline GBP 0.26 0.29 2025-12
Grifols EUR 0.29 0.11 2026-03
Ionis Pharmaceuticals USD -1.41 0.61 2025-12
J&J USD 2.46 0.34 2025-12
Karyopharm Therapeutics USD -0.15 0.11 2024-12
Merck USD 2.04 0.54 2025-12
Novartis USD 1.54 0.5 2025-12
Omeros USD -1.12 0.37 2024-06
Pfizer USD 0.66 0.21 2025-12
Roche Holding CHF 8.37 2.95 2025-12
Sangamo BioSciences USD -0.18 0.1 2024-06
Sanofi EUR 1.53 1.38 2025-12
Sarepta Therapeutics USD -3.58 3.45 2025-12
Tectonic Therapeutic USD -1.03 0.01 2025-12
Ultragenyx Pharmaceutical USD -1.29 0.52 2025-12
Vertex Pharmaceuticals USD 5.03 0.23 2025-12